Domain (Residue #) | Peptide Sequence | Monoiostopioc M r Calculated Observed | Modifications | Ratio | |
---|---|---|---|---|---|
RING I | 235NITCITCTDVR245 | 1326.59 | 1326.56 | Cys-CAM (C); Cys-SO2H (C) | 13.2 |
(238 - 293) | 235NITCITCTDVR245 | 1333.55 | 1333.62 | 2 Cys-SO3H | n/a |
 | 235NITCITCTDVRSPVLVFQCNSR256 | 2605.19 | 2605.18†| Cys-CAM; Cys-SO2H; Cys-SO3H | n/a |
 | 246SPVLVFQCNSR256 | 1296.61 | 1296.58 | Cys-SO3H | n/a |
 | 257HVICLDCFHLYCVTRLNDR275 | 2367.09 | 2367.19* | Cys-SO3H | 3.6 |
IBR | 350VTCEGGNGLGCGFAFCRECK369 | 2154.86 | 2154.90 | Cys-CAM; Cys-SO3H | n/a |
(294 - 417) | 370EAYHEGECSAVFEASGTTTQAYR392 | 2554.06 | 2554.09 | Cys-SO3H | n/a |
RING II | 428NGGCMHMK435 | 956.31 | 956.33 | 2 Oxidation (Met); Cys-SO3H | n/a |
(418 - 449) | 428NGGCMHMKCPQPQCR442 | 1882.70 | 1882.77 | 2 Cys-CAM; 2 Oxidation (Met); Cys-SO3H | n/a |
 | 436CPQPQCR442 | 862.34 | 862.40 | Cys-SO2H | n/a |
Others | 130DSPPAGSPAGRSIYNSFYVYCK151 | 2410.09 | 2410.15 | Cys-SO2H (C) | 8.1 |
(1 - 237) | 171QATLTLTQGPSCWDDVLIPNR191 | 2375.14 | 2375.15 | Cys-SO3H (C) | n/a |
 | 192MSGECQSPHCPGTSAEFFFK211 | 2236.89 | 2236.94 | Cys-SO3H (C) | 69.1 |
 | 192MSGECQSPHCPGTSAEFFFK211 | 2309.90 | 2309.93 | Cys-CAM (C); Oxidation (Met); Cys-SO3H (C) | n/a |